Acceptance and safety of directly observed versus self-administered isoniazid preventive therapy in aboriginal peoples in British Columbia

International Journal of Tuberculosis and Lung Disease

Volumn 2, Issue 12, 1998, Pages 979-983

  Heal, G ^a   Elwood, R K ^a   FitzGerald, J M ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Aboriginal; Chemoprophylaxis; Directly observed; Intermittent; Isoniazid

Indexed keywords

ISONIAZID;

ABORIGINE; ADULT; ARTICLE; CANADA; CHEMOPROPHYLAXIS; CONTROLLED STUDY; FATIGUE; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPATHY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RASH; SELF MEDICATION; SYSTEMIC LUPUS ERYTHEMATOSUS; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ADULT; ANTITUBERCULAR AGENTS; BRITISH COLUMBIA; FEMALE; HUMANS; INDIANS, NORTH AMERICAN; ISONIAZID; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; RETROSPECTIVE STUDIES; SELF ADMINISTRATION; TUBERCULOSIS, PULMONARY;

EID: 0032445827     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Rieder H. Epidemiology of tuberculosis in Europe. Eur Respir J 1995; 8 (Suppl): 620S-632S.
2. Centres for Disease Control and Prevention. Expanded tuberculosis surveillance and tuberculosis morbidity: United States, 1993. MMWR Morb Mortal Wkly Rep. 1994; 43: 361-366.
3. Centers for Disease Control and Prevention. Tuberculosis morbidity: United States, 1995. MMWR 1996; 45: 365-370.
4. FitzGerald J M, De Buncio A, Branckner A. Recent trends in tuberculosis in Canada 1979-89. Am Rev Respir Dis 1993; 147: Abstract A118.
5. FitzGerald J M, ed. Essentials of tuberculosis control for the practicing physician: a statement by the Tuberculosis Committee of the Canadian Thoracic Society. Can Med Assoc J 1994; 150: 1561-1571.
6. FitzGerald J M, ed. Tuberculosis standards. 4th ed. Ottawa; Canadian Lung Association 1996.
7. Wobeser W, To T, Hoeppner V. The outcome of chemoprophylaxis on tuberculosis prevention in the Canadian Plains Indian. Clin Invest Med 1988; 12: 149-153.
8. Steele M A, Burk R F, DesPrez R M. Toxic hepatitis with isoniazid and rifampin. A meta-analysis. Chest 1991; 9: 465-471.
9. FitzGerald J M, Gafni A. A cost effectiveness analysis of isoniazid prophylaxis versus no isoniazid prophylaxis in patients with a positive skin test. Am Rev Respir Dis 1990; 142: 848-853.
10. Halsey N A, Coberly J S, Desmormeaux J, et al. Randomized trial of isoniazid versus rifampin and pyrazinamide for prevention of tuberculosis in HIV-infection. Lancet 1998; 351: 786-791.
11. Graham N M, Galai N, Nelson K E, et al. Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease. Arch Intern Med 1996; 156: 889-894.
12. Kohn M R, Arden M R, Vasilakis J, Shenker R. Directly observed preventive therapy. Turning the tide against tuberculosis. Arch Pediatr Adolesc Med 1996; 150: 727-729.
13. Nolan C M, Nazar-Stewart V. Results of a directly observed intermittent isoniazid preventive therapy program in a shelter for homeless men. Am Rev Respir Dis 1992; 146: 57-60.
14. Small P, Hopewell P C, Singh S P, et al. The epidemiology of tuberculosis in San Francisco: a population based study using conventional and molecular methods. N Engl J Med 1994; 330: 406-109.
15. Genewein A, Telenti A, Bernasconi C, et al. Molecular approach to identifying route of transmission of tuberculosis in the community. Lancet 1993; 342: 841-844.
16. Hayward A C. Restriction fragment length polymorphism typing of Mycobacterium tuberculosis. Thorax 1995; 50: 1211-1218.
17. FitzGerald J M, Kunimoto D, and the Canadian Molecular Epidemiology of Tuberculosis Study Group. A prospective evaluation of TB cases in Western Canada and Montreal using RFLP fingerprinting. Am J Respir Crit Care Med 1997; 155 (Suppl): Abstract A224.
18. International Union against Tuberculosis Committee on Prophylaxis. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years follow-up in the IUATLD trial. Bull World Health Organ 1982; 60: 555-564.
19. Comstock G W, Baum C, Snider D. Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies. Am Rev Respir Dis 1979; 119: 827-830.
20. Sorresso D J, Mehta J B, Harvill L M, Bentley S. Underutilisation of isoniazid chemoprophylaxis in tuberculosis contacts 50 years of age and older. A prospective analysis. Chest 1995; 108; 706-711.
21. Glassroth J, Bailey W C, Hopewell P C, Schecter G, Harden J W. Why tuberculosis is not prevented. Am Rev Respir Dis 1990; 141; 1236-1240.
22. Chaulk C P, Moore-Rice K, Rizzo R, Chaisson R E. Eleven years of community based directly observed therapy for tuberculosis. JAMA 1995; 274: 945-951.
23. Baohong J I, Truffot-Pernot C, Lacroix C, et al. Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy for tuberculosis in mice. Am Rev Respir Dis 1993; 148: 1541-1546.
24. Chapus L, Baohong J I, Truffot-Pernot C, O'Brien R J, Raviglione M C, Grosser J H. Preventive therapy of tuberculosis with rifapentine in immunocompetent and nude mice. Am J Respir Crit Care Med 1994; 150: 1355-1362.
25. Geiter L J, O'Brien R J, Kopanoff D E. Short course preventive therapy. Am Rev Respir Dis 1990; 141 (4 part 2): Abstract A437.
26. Grazcyk J, O'Brien R J, Bek E, Nimerowska H, Geiter L J. Assessment of rifampin containing regimens for tuberculous preventive therapy: preliminary results from a pilot study in Poland. Am Rev Respir Dis 1991; 143 (4 part 2): Abstract A119.
27. FitzGerald J M, Patrick D, Strathdee S, et al. Prevalence of tuberculosis infection in a population of intravenous drug users. Am J Respir Crit Care 1997; 155 (4 part 2): Abstract A221.
28. Dolan J G, Bordley D R. Isoniazid prophylaxis: the importance of individual values. Med Decis Making 1994; 14: 1-8.
29. Blenkush M, Kunimoto D, Black W A, Elwood R K, FitzGerald J M. Evidence for TB clustering in Vancouver: results from a pilot study using RFLP finger-printing. Can Commun Dis 1996; 22-7: 49-51.
30. Barnes P F, El-Hajj H, Preston-Martin S, et al. Transmission of tuberculosis among the urban homeless. JAMA 1996; 275: 305-307.
31. Polesky A, Farber H W, Gottlieb D J, et al. Rifampin preventive therapy for tuberculosis in Boston's homeless. Am J Respir Crit Care Med 1996; 154: 1473-1477.
32. Chia S, Karim M, Elwood R K, FitzGerald J M. Risk of tuberculosis in dialysis patients; a population based study. Am J Respir Crit Care Med 1997; 55 (4 part 2): Abstract A338.